Anti-SERPINB13 monoclonal antibody
Pre-made anti-SERPINB13 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to SERPINB13/SERPINB13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1616-Ab-1/ GM-Tg-hg-IP1616-Ab-2 | Anti-Human SERPINB13 monoclonal antibody | Human |
GM-Tg-rg-IP1616-Ab-1/ GM-Tg-rg-IP1616-Ab-2 | Anti-Rat SERPINB13 monoclonal antibody | Rat |
GM-Tg-mg-IP1616-Ab-1/ GM-Tg-mg-IP1616-Ab-2 | Anti-Mouse SERPINB13 monoclonal antibody | Mouse |
GM-Tg-cynog-IP1616-Ab-1/ GM-Tg-cynog-IP1616-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SERPINB13 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1616-Ab-1/ GM-Tg-felg-IP1616-Ab-2 | Anti-Feline SERPINB13 monoclonal antibody | Feline |
GM-Tg-cang-IP1616-Ab-1/ GM-Tg-cang-IP1616-Ab-2 | Anti-Canine SERPINB13 monoclonal antibody | Canine |
GM-Tg-bovg-IP1616-Ab-1/ GM-Tg-bovg-IP1616-Ab-2 | Anti-Bovine SERPINB13 monoclonal antibody | Bovine |
GM-Tg-equg-IP1616-Ab-1/ GM-Tg-equg-IP1616-Ab-2 | Anti-Equine SERPINB13 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1616-Ab-1/ GM-Tg-hg-IP1616-Ab-2; GM-Tg-rg-IP1616-Ab-1/ GM-Tg-rg-IP1616-Ab-2; GM-Tg-mg-IP1616-Ab-1/ GM-Tg-mg-IP1616-Ab-2; GM-Tg-cynog-IP1616-Ab-1/ GM-Tg-cynog-IP1616-Ab-2; GM-Tg-felg-IP1616-Ab-1/ GM-Tg-felg-IP1616-Ab-2; GM-Tg-cang-IP1616-Ab-1/ GM-Tg-cang-IP1616-Ab-2; GM-Tg-bovg-IP1616-Ab-1/ GM-Tg-bovg-IP1616-Ab-2; GM-Tg-equg-IP1616-Ab-1/ GM-Tg-equg-IP1616-Ab-2 |
Products Name | Anti-SERPINB13 monoclonal antibody |
Format | mab |
Target Name | SERPINB13 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-SERPINB13 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1616-Ag-1 | Recombinant multi-species SPB13/ SERPINB13/ HSHUR7SEQ protein |
ORF Viral Vector | pGMLP003637 | human SERPINB13 Lentivirus plasmid |
ORF Viral Vector | vGMLP003637 | human SERPINB13 Lentivirus particle |
Target information
Target ID | GM-IP1616 |
Target Name | SERPINB13 |
Gene ID | 5275,241196,304690,701078,483955,101084064,100051229 |
Gene Symbol and Synonyms | 5430417G24,headpin,HSHUR7SEQ,HUR7,HURPIN,PI13,SERPINB13 |
Uniprot Accession | Q9UIV8 |
Uniprot Entry Name | SPB13_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000197641 |
Target Classification | N/A |
The target: SERPINB13, gene name: SERPINB13, also named as HSHUR7SEQ, HUR7, PI13, headpin. The protein encoded by this gene is a member of the serpin family of serine protease inhibitors. The encoded protein inhibits the activity of cathepsin K and is itself transcriptionally repressed by RUNX1. This gene is downregulated in many types of cancer. [provided by RefSeq, Jan 2017].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.